Oxford, UK - 9th April 2010
InhibOx's Paul Finn discusses the potential of on-demand hardware and Software as a Service delivery mechanisms to transform drug discovery research in a recent article for Projects Magazine, a leading research and development publication in the areas of science and technology.
